Agenus, Inc. (AGEN) Reports In-Line Q2 Loss of 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts AGEN Hot Sheet
Price: $6.33 -2.76%
Financial Fact:
Research and development: -21.59M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Research and development: -21.59M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Agenus, Inc. (NASDAQ: AGEN) reported Q2 loss of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $786 thousand versus the consensus estimate of $640 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agenus drug combo shows high response rate in colon cancer trial
- Agenus to Provide Third Quarter 2026 Financial Report and Development Update
- American Express (AXP) Tops Q3 EPS by 84c, Misses on Revenue, Raises FY Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
